Women in Endocrinology at 40: ENDO 2015

San Diego, CA US

Women in Endocrinology (WE) Annual Meeting/Dinner

Come join us for the 40th year celebration of Women in Endocrinology. Past WE and Endocrine Society President Dr. Janet Hall will be the keynote speaker to discuss the proud history and pioneering work of WE. Additional presentations will include: the WE mentor award, Award for Excellence in Basic Science Research, Award for Excellence in Clinical Research and the Young Investigator Awards.

Target Audience

This continuing medical education activity should be of substantial interest to Adult and Pediatric Endocrinologists, Internal Medicine and Primary Care Physicians, Nurses, Nurse Practitioners and Fellows.

Learning Objectives

  • To understand the data that on the lack of women in leadership positions in the Endocrine Society that led to the formation of Women in Endocrinology.
  • To review the progress in the role of women in the Endocrine Society in comparison to a number of other societies.
  • To discuss potential contributors to the relative success of Women in Endocrinology.
  • Strategies for continuing the advancement of women in endocrinology through leadership organizations, clinical and scientific practice, and patient care.

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Topic Area: 
Quality Improvement and Healthcare Delivery
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credits
  • 0.50 CME Certificate of Participation
Course opens: 
Course expires: 
Hilton San Diego Bayfront
1 Park Boulevard
San Diego, CA 92101
United States

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity: Dana Erickson, MD is a Researcher for Novartis; Ildinko Lingvay,MD is a Principal Investigator for Novo Nordisk, Author for Sanofi and member of Astra Zeneca Advisory Board; Whitney Woodmansee, MD is a Principal Investigator on Clinical Research Trials sponsored by Ipsen and Novo Nordisk

The following faculty reported no relevant financial relationships: Kimberly Cox, MD; Janet Hall, MD; Janice Kerr, MD; Erica Marsh, MD; Theresa Montales,MD; Janet Perkins, MD; Mary Rhee, MD; Carol Sartorius, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Available Credit

  • 0.50 AMA PRA Category 1 Credits
  • 0.50 CME Certificate of Participation